Skip to main content Accessibility help


  • H V WRIGHT (a1) and D J WILLIAMS (a2)


Thyrotoxicosis affects approximately 1:500 women of reproductive age. Untreated or poorly controlled thyrotoxicosis in pregnancy is associated with significant maternal and perinatal morbidity. Recognition and diagnosis of new onset thyrotoxicosis in pregnancy can be challenging as many of the symptoms can be misattributed to physiological adaptation of normal pregnancy. Women with hyperemesis gravidarum (HG) often have biochemical, but not clinical evidence of thyrotoxicosis, which does not need treatment with anti-thyroid drugs (ATDs). For women with clinical thyrotoxicosis, uncertainty regarding the risks of teratogenicity due to ATDs has led to new guideline recommendations for their use in pregnancy. Women with autoimmune diseases such as type I diabetes and who have thyroid peroxidase antibodies (TPOAb) are at an increased risk of developing postpartum thyroiditis, which can result in permanent hypothyroidism. This review summarises the management of thyrotoxicosis in pregnancy and highlights controversial areas for which conclusive evidence is still lacking.


Corresponding author

H V Wright, University College London Hospitals, London, UK. Email:


Hide All
1Glinoer, D, De, NP, Robyn, C, Lejeune, B, Kinthaert, J, Meuris, S. Serum levels of intact human chorionic gonadotropin (HCG) and its free alpha and beta subunits, in relation to maternal thyroid stimulation during normal pregnancy. J Endocrinol Invest 1993 Dec 16 (11): 881–8.
2Fantz, CR, Dagogo-Jack, S, Ladenson, JH, Gronowski, AM. Thyroid function during pregnancy. Clin Chem 1999 Dec 45 (12): 2250–58.
3De, GL, Abalovich, M, Alexander, EK, Amino, N, Barbour, L, Cobin, RH, et al.Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012 Aug 97 (8): 2543–65.
4Nor Azlin, MI, Bakin, YD, Mustafa, N, Wahab, NA, Johari, MJ, Kamarudin, NA, et al.Thyroid autoantibodies and associated complications during pregnancy. J Obstet Gynaecol 2010 30 (7): 675–8.
5Negro, R, Schwartz, A, Gismondi, R, Tinelli, A, Mangieri, T, Stagnaro-Green, A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab 2010 Apr 95 (4): 1699–707.
6Glinoer, D. The systematic screening and management of hypothyroidism and hyperthyroidism during pregnancy. Trends Endocrinol Metab 1998 Dec 9 (10): 403–11.
7Tan, JY, Loh, KC, Yeo, GS, Chee, YC. Transient hyperthyroidism of hyperemesis gravidarum. BJOG 2002 Jun 109 (6): 683–8.
8Yeo, CP, Khoo, DH, Eng, PH, Tan, HK, Yo, SL, Jacob, E. Prevalence of gestational thyrotoxicosis in Asian women evaluated in the 8th to 14th weeks of pregnancy: correlations with total and free beta human chorionic gonadotrophin. Clin Endocrinol (Oxf) 2001 Sep 55 (3): 391–8.
9Jorgensen, KT, Nielsen, NM, Pedersen, BV, Jacobsen, S, Frisch, M. Hyperemesis, gestational hypertensive disorders, pregnancy losses and risk of autoimmune diseases in a Danish population-based cohort. J Autoimmun 2012 May 38(23): J12028.
10Casey, BM, Dashe, JS, Wells, CE, McIntire, DD, Leveno, KJ, Cunningham, FG. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 2006 Feb 107 (2 Pt 1): 337–41.
11Su, PY, Huang, K, Hao, JH, Xu, YQ, Yan, SQ, Li, T, et al.Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in China. J Clin Endocrinol Metab 2011 Oct 96 (10): 3234–41.
12Negro, R, Mestman, JH. Thyroid disease in pregnancy. Best Pract Res Clin Endocrinol Metab 2011 Dec 25 (6): 927–43.
13Mitsuda, N, Tamaki, H, Amino, N, Hosono, T, Miyai, K, Tanizawa, O. Risk factors for developmental disorders in infants born to women with Graves disease. Obstet Gynecol 1992 Sep 80 (3 Pt 1): 359–64.
14Rasmussen, SA, Yazdy, MM, Carmichael, SL, Jamieson, DJ, Canfield, MA, Honein, MA. Maternal thyroid disease as a risk factor for craniosynostosis. Obstet Gynecol 2007 Aug 110 (2 Pt 1): 369–77.
15Rotondi, M, Cappelli, C, Pirali, B, Pirola, I, Magri, F, Fonte, R, et al.The effect of pregnancy on subsequent relapse from Graves’ disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab 2008 Oct 93 (10): 3985–8.
16Benhaim, RD, Davies, TF. Increased risk of Graves’ disease after pregnancy. Thyroid 2005 Nov 15 (11): 1287–90.
17Rotondi, M, Pirali, B, Lodigiani, S, Bray, S, Leporati, P, Chytiris, S, et al.The post partum period and the onset of Graves’ disease: an overestimated risk factor. Eur J Endocrinol 2008 Aug 159 (2): 161–5.
18Nagasaki, T, Inaba, M, Fujiwara-Ueda, M, Nishio, J, Kumeda, Y, Hiura, Y, et al.Thyroid blood flow as a useful predictor of relapse of Graves’ disease after normal delivery in patients with Graves’ disease. Biomed Pharmacother 2010 Feb 64 (2): 113–7.
19Hamada, N, Momotani, N, Ishikawa, N, Yoshimura, NJ, Okamoto, Y, Konishi, T, et al.Persistent high TRAb values during pregnancy predict increased risk of neonatal hyperthyroidism following radioiodine therapy for refractory hyperthyroidism. Endocr J 2011 58 (1): 55–8.
20Cooper, DS. Antithyroid drugs. N Engl J Med 2005 Mar 3 352 (9): 905–17.
21Mortimer, RH, Cannell, GR, Addison, RS, Johnson, LP, Roberts, MS, Bernus, I. Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab 1997 Sep 82 (9): 3099–102.
22Momotani, N, Noh, JY, Ishikawa, N, Ito, K. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves’ hyperthyroidism. J Clin Endocrinol Metab 1997 Nov 82 (11): 3633–36.
23Ferraris, S, Valenzise, M, Lerone, M, Divizia, MT, Rosaia, L, Blaid, D, et al.Malformations following methimazole exposure in utero: an open issue. Birth Defects Res A Clin Mol Teratol 2003 Dec 67 (12): 989–92.
24Guignon, AM, Mallaret, MP, Jouk, PS. Carbimazole-related gastroschisis. Ann Pharmacother 2003 Jun 37 (6): 829–31.
25Rodriguez-Garcia, C, Gonzalez-Hernandez, S, Hernandez-Martin, A, Perez-Robayna, N, Sanchez, R, Torrelo, A. Aplasia cutis congenita and other anomalies associated with methimazole exposure during pregnancy. Pediatr Dermatol 2011 Nov 28 (6): 743–5.
26Yoshihara, A, Noh, J, Yamaguchi, T, Ohye, H, Sato, S, Sekiya, K, et al.Treatment of Graves’ disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab 2012 Jul 97 (7): 2396–403.
27Bowman, P, Osborne, NJ, Sturley, R, Vaidya, B. Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy. QJM 2012 Feb 105 (2): 189–93.
28Singh, S, Pandey, A, Ahmed, I, Rawat, JD, Sharma, A, Srivastava, NK. Prolapse of bowel via patent vitello intestinal duct–a rare occurrence. Hernia 2011 Oct 15 (5): 567–9.
29Rivkees, SA, Mandel, SJ. Thyroid disease in pregnancy. Horm Res Paediatr 2011 76(Suppl 1): 91–6.
30Benavides, VC, Mallela, MK, Booth, CJ, Wendler, CC, Rivkees, SA. Propylthiouracil is teratogenic in murine embryos. PLoS One 2012 7 (4): e35213.
31Di, GE, Schaefer, C, Mastroiacovo, PP, Cournot, MP, Benedicenti, F, Reuvers, M, et al.Adverse effects of prenatal methimazole exposure. Teratology 2001 Nov 64 (5): 262–6.
32Kuy, S, Roman, SA, Desai, R, Sosa, JA. Outcomes following thyroid and parathyroid surgery in pregnant women. Arch Surg 2009 May 144 (5): 399406.
33Lowe, SA. Diagnostic radiography in pregnancy: risks and reality. Aust N Z J Obstet Gynaecol 2004 Jun 44 (3): 191–6.
34Laurberg, P, Nygaard, B, Glinoer, D, Grussendorf, M, Orgiazzi, J. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol 1998 Dec 139 (6): 584–6.
35Friedland, DR, Rothschild, MA. Rapid resolution of fetal goiter associated with maternal Grave's disease: a case report. Int J Pediatr Otorhinolaryngol 2000 Aug 11 54 (1): 5962.
36Momotani, N, Ito, K, Hamada, N, Ban, Y, Nishikawa, Y, Mimura, T. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol (Oxf) 1984 Jun 20 (6): 695700.
37Laurberg, P, Bournaud, C, Karmisholt, J, Orgiazzi, J. Management of Graves’ hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol 2009 Jan 160 (1): 18.
38Kempers, MJ, van Tijn, DA, van Trotsenburg, AS, de Vijlder, JJ, Wiedijk, BM, Vulsma, T. Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. J Clin Endocrinol Metab 2003 Dec 88 (12): 5851–7.
39Amino, N, Miyai, K, Onishi, T, Hashimoto, T, Arai, K. Transient hypothyroidism after delivery in autoimmune thyroiditis. J Clin Endocrinol Metab 1976 Feb 42 (2): 296301.
40Negro, R, Greco, G, Mangieri, T, Pezzarossa, A, Dazzi, D, Hassan, H. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 2007 Apr 92 (4): 1263–8.
41Jaen Diaz, JI, Lopez De, CF, Cordero, GB, Santillana, BF, Sastre, MJ, Martin Dal, GC. Incidence of postpartum thyroiditis and study of possible associated factors. Med Clin (Barc) 2009 Apr 25 132 (15): 569–73.
42Alvarez-Marfany, M, Roman, SH, Drexler, AJ, Robertson, C, Stagnaro-Green, A. Long-term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1994 Jul 79 (1): 10–6.
43Galanti, MR, Cnattingius, S, Granath, F, Ekbom-Schnell, A, Ekbom, A. Smoking and environmental iodine as risk factors for thyroiditis among parous women. Eur J Epidemiol 2007 22 (7): 467–72.
44Belin, RM, Astor, BC, Powe, NR, Ladenson, PW. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2004 Dec 89 (12): 6077–86.
45Nohr, SB, Jorgensen, A, Pedersen, KM, Laurberg, P. Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody-positive women living in an area with mild to moderate iodine deficiency: is iodine supplementation safe? J Clin Endocrinol Metab 2000 Sep 85 (9): 3191–8.
46Manetti, L, Parkes, AB, Lupi, I, Di, CG, Bogazzi, F, Albertini, S, et al.Serum pituitary antibodies in normal pregnancy and in patients with postpartum thyroiditis: a nested case-control study. Eur J Endocrinol 2008 Dec 159 (6): 805–9.
47Stuckey, BG, Kent, GN, Allen, JR, Ward, LC, Brown, SJ, Walsh, JP. Low urinary iodine postpartum is associated with hypothyroid postpartum thyroid dysfunction and predicts long-term hypothyroidism. Clin Endocrinol (Oxf) 2011 May 74 (5): 631–5.
48Stagnaro-Green, A, Schwartz, A, Gismondi, R, Tinelli, A, Mangieri, T, Negro, R. High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroiditis in southern Italy. J Clin Endocrinol Metab 2011 Mar 96 (3): 652–7.
49Kent, GN, Stuckey, BG, Allen, JR, Lambert, T, Gee, V. Postpartum thyroid dysfunction: clinical assessment and relationship to psychiatric affective morbidity. Clin Endocrinol (Oxf) 1999 Oct 51 (4): 429–38.
50Harris, B, Othman, S, Davies, JA, Weppner, GJ, Richards, CJ, Newcombe, RG, et al.Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ 1992 Jul 18 305 (6846): 152–6.
51Cotzias, C, Wong, SJ, Taylor, E, Seed, P, Girling, J. A study to establish gestation-specific reference intervals for thyroid function tests in normal singleton pregnancy. Eur J Obstet Gynecol Reprod Biol 2008 Mar 137 (1): 61–6.

Related content

Powered by UNSILO


  • H V WRIGHT (a1) and D J WILLIAMS (a2)


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.